Navigation Links
Watson to Present at Credit Suisse Healthcare Conference
Date:11/6/2009

MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern Standard Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL: http://w.on24.com/r.htm?e=174718&s=1&k=2A3BE5C03C41AC87564EA340841EC356

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical. For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)

SOURCE Watson Pharmaceuticals, Inc.


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Tenn., Nov. 20 Smith ... is pleased to announce the signing of a technolog...rtment of Defense that may lead to the creation of...ize the treatment of the limbs of soldiers who sus...fense Advanced Research Projects Agency (DARPA), t...
(Date:11/19/2009)...rance, Nov. 19 In response to an e...ous and illegal medicines, Operation Pangea II, in...and the World Health Organization,s International ...PACT) to highlight the dangers of buying medicines...ulted in a series of arrests and the seizure of th...
(Date:11/19/2009)...Ohio, Nov. 19 Riverain Medical ann...ith leading Canadian medical imaging distributor C...ging and OnGuard Chest Xray CAD. The exclusive agr...cal,s products to the Canadian market through Chri...el. ,, SoftView Enhanced Chest Imaging increase...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2HMS Holdings Corp to Present at Investor Conferences 56627 1Peripheral Arterial Disease 3A Simple Quiz Keeps You Circulating 56626 1Peripheral Arterial Disease 3A Simple Quiz Keeps You Circulating 56626 2Peripheral Arterial Disease 3A Simple Quiz Keeps You Circulating 56626 3Peripheral Arterial Disease 3A Simple Quiz Keeps You Circulating 56626 4Peripheral Arterial Disease 3A Simple Quiz Keeps You Circulating 56626 5Research Firm will Obtain Americans Reactions to the Presidents Speech on Health Care Reform 56623 1Research Firm will Obtain Americans Reactions to the Presidents Speech on Health Care Reform 56623 2
(Date:11/20/2009)...wire/ -- Today, iconic denim brand DKNY JEANS an...f a capsule gift giving collection offered exclusi...his collection is inspired by and designed for St.... Giving® Program, a holiday fundraising and ...ive thanks for the healthy kids in your lives and ...
(Date:11/20/2009)...Newswire-USNewswire/ -- The US government reported...et enough food to eat. This startling statistic h... rapidly aging into poverty. "Forced retirements,...n many have incomes that no longer cover the basic...men are particularly vulnerable," said Kate White ...
(Date:11/20/2009)...re/ --The United States Senate is about to conside...a 5% tax on cosmetic surgery deemed unnecessary fo...l Plastic and Reconstructive Surgery (AAFPRS) anno...x as it is discriminatory and has already failed i...x will go into effect on January 1, 2010, in hopes...
(Date:11/20/2009)...thcare® is pleased to announce its agreement w...deliver multispecialty physicians for locum tenens...physician placement. , Al...Healthcare is pleased to announce its agreement wi...eliver multispecialty physicians for locum tenens ...
(Date:11/20/2009)...Newswire-USNewswire/ -- POLITICO recently publis... Manufacturers of America (PhRMA) Senior Vice Pre...s the case for health reform and reaffirm,s PhRMA,..., Johnson states the plight of the uninsured an... PhRMA,s position that everyone in America should...
Breaking Medicine News(10 mins):Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:AAFPRS Opposes the Proposed Tax on Medical Procedures 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 2Health News:VHA Names Jackson Healthcare as Preferred Physician Staffing Vendor 3
...Dash(R) Kicks off Virtual Women,s Heart Health Das...r Women with Heart Disease , , CHICAGO, Feb. 3 ...ng across the country for a good cause? Well, now ... the U.S.* -- Mrs. Dash(R) is kicking off the Wom...
...TH, Texas, Feb. 3 Galderma Laboratories, L.P.,tod...ation (FDA) has approved,Vectical(TM) (calcitriol)...the,treatment of mild-to-moderate plaque psoriasis...tches of skin and,caused by an abnormally high gro...
...CH, Va., Feb. 3, 2009 AMERIGROUP Corporation (NYS...q., MPH has been named Chief Compliance Officer, a...pany operations comply with state and federal laws...at AMERIGROUP," said John E. Littel, AMERIGROUP Ex...
... Feb. 3 When Americans are asked about the kids i... Poll, commissioned by the,National Court Appointe...83,percent of adults know little or nothing about ...n foster care, only a minority,(11 percent) cited ...
... Elevated to Chief Marketing Officer and PACS Indu...(TM) General Manager , , WASHINGTON, Feb. 3 Comp...eroperability solutions, bolstered its executive t... the MEDxConnect(TM) division. , , Proven to incr...
... Shandong, China, Feb. 3 /PRNewswire-Asia-FirstCal...Board: SGTI) ("Shengtai Pharmaceutical" or,"the Co... high-quality,pharmaceutical grade glucose product... , This conference will be held from Monday, F...
Other Medicine News:Health News:It's a Mad Dash in the Race Against Heart Disease 2Health News:It's a Mad Dash in the Race Against Heart Disease 3Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 2Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 3Health News:Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis 4Health News:AMERIGROUP Names Finley Chief Compliance Officer 2Health News:National CASA Association Aims to Eliminate the Foster Care Stigma 2Health News:Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM) 2Health News:Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM) 3Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 2Health News:Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference 3
The EXTENDED FIT
The PANORAMA
Jarrod Goggle
Clip-On
Medicine Products: